Phase 1 Study of HBN-1

Status unconfirmed · Phase 1

Conditions studied: Cardiac Arrest

In brief

Phase 1 First-in Human randomized, open-label, active control standard of care study of the safety of HBN-1 administered as pharmacologically induced hypothermia as an adjunct to standard of care targeted temperature management in adult patients who have experienced out-of-hospital-cardiac arrest. HBN-1 will be administered IV as a loading dose infusion followed by a 12-hour maintenance infusion.

Key facts

Study ID
NCT04094857
Run by
Hibernaid, Inc
People needed
18
Starts
2019-10-30
Expected to finish
2020-12-31
Last updated by the study team
2019-10-07

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.